Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162316 (
iron deficiency anemia
)
3,806
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Reticulocyte analysis was studied in 28 anemic patients, 15 with
iron deficiency anemia
(
IDA
), and 13 with hemolytic anemia including 9 glucose 6 phosphate dehydrogenase deficiency (
G6PD
def.), and 4 with
G6PD
def. combined with HbE trait or alpha thalassemia trait (alpha thal trait). The reticulocyte analysis among these patients showed the increased number of reticulocyte percentage with low degree of maturation in both
IDA
and
G6PD
def. patients. The significantly decreased reticulocyte hemoglobin content (CHr) was found in
IDA
(CHr = 21.74 +/- 4.61 pg in
IDA
vs 28.41 +/- 1.34 pg in normal; p-value = < 0.0001), whereas, increased CHr was found in
G6PD
def. patients. In addition, the
G6PD
def. patients also showed a significant increase in mean corpuscular reticulocyte volume (MCVr) when compared to normal (MCVr = 132.0 +/- 8.39 fl. in
G6PD
def. vs 110.39 +/- 5.09 in normal; p-value = < 0.0001). However, a significant decrease in MCVr was found in
IDA
patients (MCVr = 95.89 +/- 8.57 fl.; p-value = < 0.0001 vs normal). From this study, we can suggest that the reticulocyte hemoglobin content (CHr) and mean corpuscular reticulocyte volume (MCVr) are the important defects in patients with
iron deficiency anemia
.
...
PMID:Reticulocyte analysis in iron deficiency anemia and hemolytic anemia. 1086 17